Loading clinical trials...
Loading clinical trials...
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Reference Study ID Number: WP45722 https://forpatients.roche.com/
CONTACT
888-662-6728 (U.S. and Canada)global-roche-genentech-trials@gene.comLead Sponsor
Hoffmann-La Roche
NCT07170150 · Alzheimers Disease
NCT06484244 · Alzheimers Disease, Mild Cognitive Impairment
NCT01760005 · Alzheimers Disease, Dementia, and more
NCT07212062 · Alzheimers Disease
NCT06996730 · Autosomal Dominant Alzheimers Disease, Early Onset Alzheimer Disease, and more
Banner Alzheimer?s Institute
Phoenix, Arizona
Banner Sun Health Research Institute
Sun City, Arizona
Sun Valley Research Center, Inc.
Imperial, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions